Invivo Therapeutics Holdings Corp


Analysts Shine Light On Two Volatile Healthcare Stocks: Celldex Therapeutics, Inc. (CLDX), Invivo Therapeutics Holdings Corp (NVIV)

As two biotech companies continue announce pipeline progressions, for better or worse, analysts weigh in on Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Invivo Therapeutics …

Thursday Morning’s Market Insights: Invivo Therapeutics Holdings Corp (NVIV), Prima BioMed Ltd (ADR) (PBMD), Avago Technologies Ltd (AVGO), Costco Wholesale Corporation (COST)

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) shares rose 13% this morning after the company announced that it received conditional FDA approval of a study protocol …

Stock Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that a fourth patient has been enrolled in the company’s ongoing pilot trial of its investigational Neuro- …

Company Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Announces Promotions and New Organizational Roles to Further Drive Market Development and Awareness of Spinal Cord Injury Innovation

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced promotions for two members of its management team. Christopher McNulty has been appointed as Senior Vice President, Business …

Stock Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Reports 2015 Second Quarter Financial Results and Business Update

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) reported financial results for the quarter ended June 30, 2015. Mark Perrin, Chief Executive Officer and Chairman, said, …

Company Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Reports Significant Improvement of Second and Third Patients Implanted with Neuro-Spinal Scaffold

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced a one-month post-implant update for the third study patient and a six-month post-implant update for the second …

Company Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Announces Rutgers New Jersey Medical School as New Clinical Site for Neuro-Spinal Scaffold

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that Rutgers New Jersey Medical School in Newark, NJ has been added as a clinical site in …

Stock Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Is Added to Russell Global, Russell 3000(r), Russell 2000(r), and Russell Microcap(r) Indexes

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that the company has been added to the Russell Global, Russell 3000®, Russell 2000®, and Russell Microcap …

Stock Update (NASDAQ:NVIV): Invivo Therapeutics Holdings Corp Receives Notice of Allowance on Patent Covering Broader Compositions

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for …

Stock Update (NASDAQ:NVIV): InVivo Therapeutics Co-Founder Dr. Robert Langer to Highlight InVivo Scientific Progress in Closing Keynote Address at the ISSCR 2015 Annual Meeting

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that Co-Founder Robert Langer, Sc.D.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts